Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The initial phase of the partnership, valued at up to $15m and running until 202...
Ionis will retain the responsibility for commercialising the RNA-targeted medici...
The facility, to be located at the Board of Investment zone in Horana, will be ...
Expands Schedule H2 to include vaccines, antimicrobials and anticancer drugs Th...
Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated f...
The unified platform enables users to check the prices of scheduled and non-sch...
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths Th...
The facility has received EU GMP certification from the Malta Medicines Authori...
The company informed that the facility which is fully operational, is designed ...
The authorisation applies to adults with resectable MIBC who cannot be treated w...
Frazier Life Sciences led the financing round along with new investors EQT Life ...
Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; adminis...
India’s hair restoration industry has witnessed significant growth over the las...
According to the circular, formulation intermediates intended for use in modifi...
The inspection was conducted from June 18 to June 24, 2026 The post Concord Bio...
The partnership will combine Combotope’s SMART-Phage discovery platform with Boe...